A biology-guided artificial intelligence model applied to routine pathology slides accurately predicted outcomes and response to immunotherapy in patients with metastatic non-small cell lung ...

Prostate cancer remains one of the most common diseases among men, yet current screening methods often lead to unnecessary ...

An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...

An artificial intelligence (AI) model developed by researchers at The University of Texas MD Anderson Cancer Center ...

A machine learning model analyzing CpG-based DNA methylation accurately predicted the origin of many different cancer types ...

In a National Institutes of Health (NIH)-funded study, researchers developed a cancer assessment tool that can identify high-risk patients and the tumor cells linked to that risk. The model, called ...

In a National Institutes of Health (NIH)-funded study, researchers developed a cancer assessment tool that can identify high-risk patients and the tumor cells linked to that risk.

Using a historical data set from UT MD Anderson, Path-IO separated patients into high-risk and low-risk groups. Patients in ...

Dr Oliver Hulson discusses an advanced AI software system being piloted in Leeds to help improve prostate cancer diagnosis ...

aNovo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, ...